Latest Breaking News On - Orchid pharma - Page 1 : vimarsana.com

Benchmarks reverse losses; PSU bank shares advance

Benchmarks reverse losses; PSU bank shares advance
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Indian overseas bankPunjab sind bankBikaji foods internationalCorporate agencyPage industriesMahindra financial servicesIndian bankUnion bankCentral bankCanara bankTata investment corpInterglobe aviationFortis healthcareBayer cropFinolex cablesSaregama india

Debt-free Orchid Pharma charts out growth plan

Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.

Jammu and kashmirTamil naduManish dhanukaGlobal antibiotic research development partnershipDhanuka groupOrchid antimicrobial solutionsOrchid pharmaGurugram based dhanuka laboratoriesOrchid antimicrobialAllecra therapeuticsGlobal antibiotic researchDevelopment partnershipDhanuka laboratoriesPli scheme

Crorepati stocks! 10 shares turned Rs 1 lakh to up to Rs 6 crore in 5 years

Data showed that at least 10 small-cap stocks on Dalal Street have delivered over 100 times returns to investors in the last five years.

Algoquant fintechSachin goelDivam sharmaWs industries indiaRaj rayon industriesDalal streetWaaree renewable technologies emergedWaaree renewable technologiesVice presidentBonanza portfolioDiamond power infrastructureIntegrated industriesPower infrastructureAuthum investmentHazoor multi projectsOrchid pharma

Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023

Independent Auditor s Review Report on the Quarterly and Year to date Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI Regulations, 2015 .

South africaUnited statesUnited kingdomSudesh chorariaCompany managementParent company board of directorsOrchid pharmaceuticals sa proprietaryParent company managementSinghi coInstitute of chartered accountants indiaFirm regnOrbion pharmaceuticals privateUnaudited standalone financial results of the companyCompany board of directorsFinancial results of orchid pharmaOrchid pharmaceuticals inc

Orchid Pharma : Iii Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023

Independent Auditor s Review Report on the Quarterly and Year to date Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI Regulations, 2015 .

United kingdomSouth africaUnited statesSudesh chorariaOrchid pharmaceuticals sa proprietaryParent company board of directorsCompany managementSinghi coInstitute of chartered accountants indiaFirm regnUnaudited standalone financial results of the companyOrbion pharmaceuticals privateParent company managementFinancial results of orchid pharmaCompany board of directorsBexel pharmaceuticals inc